Recommendations on the use of MRI in PSC-A position statement from the International PSC study group

Standard

Recommendations on the use of MRI in PSC-A position statement from the International PSC study group. / Schramm, Christoph; Eaton, John E; Ringe, Kristina I; Venkatesh, Sudhakar; Yamamura, Jin; MRI working group of the IPSCSG.

In: HEPATOLOGY, Vol. 66, No. 5, 11.2017, p. 1675-1688.

Research output: SCORING: Contribution to journalSCORING: Review articleResearch

Harvard

Schramm, C, Eaton, JE, Ringe, KI, Venkatesh, S, Yamamura, J & MRI working group of the IPSCSG 2017, 'Recommendations on the use of MRI in PSC-A position statement from the International PSC study group', HEPATOLOGY, vol. 66, no. 5, pp. 1675-1688. https://doi.org/10.1002/hep.29293

APA

Vancouver

Bibtex

@article{3406359fc7074560943dfb1b99617b03,
title = "Recommendations on the use of MRI in PSC-A position statement from the International PSC study group",
abstract = "Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disorder characterized by inflammation and fibrosis of the intra and/or extrahepatic bile ducts. Magnetic resonance imaging (MRI) is a noninvasive imaging modality that can be used to diagnose PSC and detect disease related complications. Quantitative MRI technologies also have the potential to provide valuable prognostic information. Despite the potential of this imaging technology, the clinical application of MRI in the care of PSC patients and imaging standards vary across institutions. Moreover, a unified position statement about the role of MRI in the care of PSC patients, quality imaging standards and its potential as a research tool is lacking.CONCLUSIONS: Members of the international PSC study group and radiologists from North America and Europe have compiled the following position statement to provide guidance regarding the application of MRI in the care of PSC patients, minimum imaging standards and future areas of research. This article is protected by copyright. All rights reserved.",
keywords = "Journal Article, Review",
author = "Christoph Schramm and Eaton, {John E} and Ringe, {Kristina I} and Sudhakar Venkatesh and Jin Yamamura and {MRI working group of the IPSCSG}",
note = "{\textcopyright} 2017 by the American Association for the Study of Liver Diseases.",
year = "2017",
month = nov,
doi = "10.1002/hep.29293",
language = "English",
volume = "66",
pages = "1675--1688",
journal = "HEPATOLOGY",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "5",

}

RIS

TY - JOUR

T1 - Recommendations on the use of MRI in PSC-A position statement from the International PSC study group

AU - Schramm, Christoph

AU - Eaton, John E

AU - Ringe, Kristina I

AU - Venkatesh, Sudhakar

AU - Yamamura, Jin

AU - MRI working group of the IPSCSG

N1 - © 2017 by the American Association for the Study of Liver Diseases.

PY - 2017/11

Y1 - 2017/11

N2 - Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disorder characterized by inflammation and fibrosis of the intra and/or extrahepatic bile ducts. Magnetic resonance imaging (MRI) is a noninvasive imaging modality that can be used to diagnose PSC and detect disease related complications. Quantitative MRI technologies also have the potential to provide valuable prognostic information. Despite the potential of this imaging technology, the clinical application of MRI in the care of PSC patients and imaging standards vary across institutions. Moreover, a unified position statement about the role of MRI in the care of PSC patients, quality imaging standards and its potential as a research tool is lacking.CONCLUSIONS: Members of the international PSC study group and radiologists from North America and Europe have compiled the following position statement to provide guidance regarding the application of MRI in the care of PSC patients, minimum imaging standards and future areas of research. This article is protected by copyright. All rights reserved.

AB - Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disorder characterized by inflammation and fibrosis of the intra and/or extrahepatic bile ducts. Magnetic resonance imaging (MRI) is a noninvasive imaging modality that can be used to diagnose PSC and detect disease related complications. Quantitative MRI technologies also have the potential to provide valuable prognostic information. Despite the potential of this imaging technology, the clinical application of MRI in the care of PSC patients and imaging standards vary across institutions. Moreover, a unified position statement about the role of MRI in the care of PSC patients, quality imaging standards and its potential as a research tool is lacking.CONCLUSIONS: Members of the international PSC study group and radiologists from North America and Europe have compiled the following position statement to provide guidance regarding the application of MRI in the care of PSC patients, minimum imaging standards and future areas of research. This article is protected by copyright. All rights reserved.

KW - Journal Article

KW - Review

U2 - 10.1002/hep.29293

DO - 10.1002/hep.29293

M3 - SCORING: Review article

C2 - 28555945

VL - 66

SP - 1675

EP - 1688

JO - HEPATOLOGY

JF - HEPATOLOGY

SN - 0270-9139

IS - 5

ER -